Exalenz Bioscience Shares Positive Clinical Trial Results for CSPH Test
The BreathID platform has shown positive clinical trial results for detecting clinically significant portal hypertension in nonalcoholic steatohepatitis patients with compensated advanced chronic liver disease.
Read More